{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T07:09:07Z","timestamp":1777100947803,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T00:00:00Z","timestamp":1571875200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,24]],"date-time":"2019-10-24T00:00:00Z","timestamp":1571875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s12149-019-01415-z","type":"journal-article","created":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T17:35:07Z","timestamp":1572024907000},"page":"58-64","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Similar T\/N ratio between 18F-FBPA diagnostic and BPA therapeutic dosages for boron neutron capture therapy in orthotropic tongue cancer model"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9680-2005","authenticated-orcid":false,"given":"Yu-Chuan","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fong-In","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bang-Hung","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Wei","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeng-Jong","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,24]]},"reference":[{"key":"1415_CR1","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1158\/1078-0432.CCR-05-0035","volume":"11","author":"RF Barth","year":"2005","unstructured":"Barth RF, Coderre JA, Vicente MG, Blue TE. Boron neutron capture therapy of cancer: current status and future prospects. Clin Cancer Res. 2005;11:3987\u20134002.","journal-title":"Clin Cancer Res"},{"key":"1415_CR2","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1023\/A:1016076022267","volume":"13","author":"SC Mehta","year":"1996","unstructured":"Mehta SC, Lu DR. Targeted drug delivery for boron neutron capture therapy. Pharm Res. 1996;13:344\u201351.","journal-title":"Pharm Res"},{"key":"1415_CR3","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1002\/1097-0142(19921215)70:12<2995::AID-CNCR2820701243>3.0.CO;2-#","volume":"70","author":"RF Barth","year":"1992","unstructured":"Barth RF, Soloway AH, Fairchild RG, Brugger RM. Boron neutron capture therapy for cancer. Realities and prospects. Cancer. 1992;70:2995\u20133007.","journal-title":"Cancer"},{"key":"1415_CR4","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s10147-013-0580-3","volume":"19","author":"T Aihara","year":"2014","unstructured":"Aihara T, Morita N, Kamitani N, Kumada H, Ono K, Hiratsuka J, et al. Boron neutron capture therapy for advanced salivary gland carcinoma in head and neck. Int J Clin Oncol. 2014;19:437\u201344.","journal-title":"Int J Clin Oncol"},{"key":"1415_CR5","first-page":"1833","volume":"4","author":"Y Imahori","year":"1998","unstructured":"Imahori Y, Ueda S, Ohmori Y, Sakae K, Kusuki T, Kobayashi T, et al. Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: part II. Clin Cancer Res. 1998;4:1833\u201341.","journal-title":"Clin Cancer Res"},{"key":"1415_CR6","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/hed.20418","volume":"28","author":"T Aihara","year":"2006","unstructured":"Aihara T, Hiratsuka J, Morita N, Uno M, Sakurai Y, Maruhashi A, et al. First clinical case of boron neutron capture therapy for head and neck malignancies using 18F-BPA PET. Head Neck. 2006;28:850\u20135.","journal-title":"Head Neck"},{"key":"1415_CR7","first-page":"5888","volume":"9","author":"Y Takahashi","year":"2003","unstructured":"Takahashi Y, Imahori Y, Mineura K. Prognostic and therapeutic indicator of fluoroboronophenylalanine positron emission tomography in patients with gliomas. Clin Cancer Res. 2003;9:5888\u201395.","journal-title":"Clin Cancer Res"},{"key":"1415_CR8","first-page":"325","volume":"39","author":"Y Imahori","year":"1998","unstructured":"Imahori Y, Ueda S, Ohmori Y, Kusuki T, Ono K, Fujii R, et al. Fluorine-18-labeled fluoroboronophenylalanine PET in patients with glioma. J Nucl Med. 1998;39:325\u201333.","journal-title":"J Nucl Med"},{"key":"1415_CR9","first-page":"1762","volume":"38","author":"GW Kabalka","year":"1997","unstructured":"Kabalka GW, Smith GT, Dyke JP, Reid WS, Longford CP, Roberts TG, et al. Evaluation of fluorine-18-BPA-fructose for boron neutron capture treatment planning. J Nucl Med. 1997;38:1762\u20137.","journal-title":"J Nucl Med"},{"key":"1415_CR10","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1016\/j.apradiso.2009.03.103","volume":"67","author":"I Kato","year":"2009","unstructured":"Kato I, Fujita Y, Maruhashi A, Kumada H, Ohmae M, Kirihata M, et al. Effectiveness of boron neutron capture therapy for recurrent head and neck malignancies. Appl Radiat Isot. 2009;67:S37\u201342.","journal-title":"Appl Radiat Isot"},{"key":"1415_CR11","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1093\/jrr\/rrt098","volume":"55","author":"M Suzuki","year":"2014","unstructured":"Suzuki M, Kato I, Aihara T, Hiratsuka J, Yoshimura K, Niimi M, et al. Boron neutron capture therapy outcomes for advanced or recurrent head and neck cancer. J Radiat Res. 2014;55:146\u201353.","journal-title":"J Radiat Res"},{"key":"1415_CR12","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.apradiso.2011.03.008","volume":"69","author":"LW Wang","year":"2011","unstructured":"Wang LW, Wang SJ, Chu PY, Ho CY, Jiang SH, Liu YWH, et al. BNCT for locally recurrent head and neck cancer: preliminary clinical experience from a phase I\/II trial at Tsing Hua Open-Pool Reactor. Appl Radiat Isot. 2011;69:1803\u20136.","journal-title":"Appl Radiat Isot"},{"key":"1415_CR13","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1080\/00365510802100831","volume":"68","author":"S Linko","year":"2008","unstructured":"Linko S, Revitzer H, Zilliacus R, Kortesniemi M, Kouri M, Savolainen S. Boron detection from blood samples by ICP-AES and ICP-MS during boron neutron capture therapy. Scand J Clin Lab Invest. 2008;68:696\u2013702.","journal-title":"Scand J Clin Lab Invest"},{"key":"1415_CR14","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1093\/clinchem\/47.10.1796","volume":"47","author":"J Laakso","year":"2001","unstructured":"Laakso J, Kulvik M, Ruokonen I, Vahatalo J, Zilliacus R, Farkkila M, et al. Atomic emission method for total boron in blood during neutron-capture therapy. Clin Chem. 2001;47:1796\u2013803.","journal-title":"Clin Chem"},{"key":"1415_CR15","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.apradiso.2004.05.033","volume":"61","author":"M Kortesniemi","year":"2004","unstructured":"Kortesniemi M, Seppala T, Auterinen I, Savolainen S. Enhanced blood boron concentration estimation for BPA-F mediated BNCT. Appl Radiat Isot. 2004;61:823\u20137.","journal-title":"Appl Radiat Isot"},{"key":"1415_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2307\/3579926","volume":"149","author":"JA Coderre","year":"1998","unstructured":"Coderre JA, Chanana AD, Joel DD, Elowitz EH, Micca PL, Nawrocky MM, et al. Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: boron concentration correlates with tumor cellularity. Radiat Res. 1998;149:163\u201370.","journal-title":"Radiat Res"},{"key":"1415_CR17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13550-014-0070-2","volume":"4","author":"K Hanaoka","year":"2014","unstructured":"Hanaoka K, Watabe T, Naka S, Kanai Y, Ikeda H, Horitsugi G, et al. FBPA PET in boron neutron capture therapy for cancer: prediction of B concentration in the tumor and normal tissue in a rat xenograft model. EJNMMI Res. 2014;4:70.","journal-title":"EJNMMI Res"},{"key":"1415_CR18","first-page":"302","volume":"45","author":"HE Wang","year":"2004","unstructured":"Wang HE, Liao AH, Deng WP, Chang PF, Chen JC, Chen FD, et al. Evaluation of 4-borono-2-F-18-fluoro-l-phenylalanine-fructose as a probe for boron neutron capture therapy in a glioma-bearing rat model. J Nucl Med. 2004;45:302\u20138.","journal-title":"J Nucl Med"},{"key":"1415_CR19","first-page":"1858","volume":"46","author":"CH Hsieh","year":"2005","unstructured":"Hsieh CH, Chen YF, Chen FD, Hwang JJ, Chen JC, Liu RS, et al. Evaluation of pharmacokinetics of 4-borono-2-F-18-fluoro-l-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption. J Nucl Med. 2005;46:1858\u201365.","journal-title":"J Nucl Med"},{"key":"1415_CR20","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1186\/s12885-016-2913-x","volume":"16","author":"T Watanabe","year":"2016","unstructured":"Watanabe T, Hattori Y, Ohta Y, Ishimura M, Nakagawa Y, Sanada Y, et al. Comparison of the pharmacokinetics between L-BPA and L-FBPA using the same administration dose and protocol: a validation study for the theranostic approach using [(18)F]-L-FBPA positron emission tomography in boron neutron capture therapy. BMC Cancer. 2016;16:859.","journal-title":"BMC Cancer"},{"key":"1415_CR21","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.ejca.2003.11.021","volume":"40","author":"MC Bibby","year":"2004","unstructured":"Bibby MC. Orthotopic models of cancer for preclinical drug evaluation: advantages and disadvantages. Eur J Cancer. 2004;40:852\u20137.","journal-title":"Eur J Cancer"},{"key":"1415_CR22","first-page":"2657","volume":"32","author":"YC Lin","year":"2012","unstructured":"Lin YC, Hwang JJ, Wang SJ, Yang BH, Chang CW, Hsiao MC, et al. Macro- and microdistributions of boron drug for boron neutron capture therapy in an animal model. Anticancer Res. 2012;32:2657\u201364.","journal-title":"Anticancer Res"},{"key":"1415_CR23","doi-asserted-by":"publisher","first-page":"503","DOI":"10.2967\/jnumed.115.154385","volume":"56","author":"W Chen","year":"2015","unstructured":"Chen W, Dilsizian V. PET assessment of vascular inflammation and atherosclerotic plaques: SUV or TBR? J Nucl Med. 2015;56:503\u20134.","journal-title":"J Nucl Med"},{"key":"1415_CR24","doi-asserted-by":"publisher","first-page":"e005131","DOI":"10.1161\/CIRCIMAGING.116.005131","volume":"9","author":"TA Pawade","year":"2016","unstructured":"Pawade TA, Cartlidge TR, Jenkins WS, Adamson PD, Robson P, Lucatelli C, et al. Optimization and reproducibility of aortic valve 18F-fluoride positron emission tomography in patients with aortic stenosis. Circ Cardiovasc Imaging. 2016;9:e005131.","journal-title":"Circ Cardiovasc Imaging"},{"key":"1415_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13550-016-0230-7","volume":"6","author":"K Isohashi","year":"2016","unstructured":"Isohashi K, Shimosegawa E, Naka S, Kanai Y, Horitsugi G, Mochida I, et al. Comparison of the image-derived radioactivity and blood-sample radioactivity for estimating the clinical indicators of the efficacy of boron neutron capture therapy (BNCT): 4-borono-2-(18)F-fluoro-phenylalanine (FBPA) PET study. EJNMMI Res. 2016;6:75.","journal-title":"EJNMMI Res"},{"key":"1415_CR26","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/00008390-199209000-00005","volume":"2","author":"K Ishiwata","year":"1992","unstructured":"Ishiwata K, Shiono M, Kubota K, Yoshino K, Hatazawa J, Ido T, et al. A unique in vivo assessment of 4-[10B]borono-l-phenylalanine in tumour tissues for boron neutron capture therapy of malignant melanomas using positron emission tomography and 4-borono-2-[18F]fluoro-l-phenylalanine. Melanoma Res. 1992;2:171\u20139.","journal-title":"Melanoma Res"},{"key":"1415_CR27","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/0883-2897(92)90116-G","volume":"19","author":"K Ishiwata","year":"1992","unstructured":"Ishiwata K, Ido T, Honda C, Kawamura M, Ichihashi M, Mishima Y. 4-Borono-2-[18F]fluoro-D, l-phenylalanine: a possible tracer for melanoma diagnosis with PET. Int J Rad Appl Instrum B. 1992;19:311\u20138.","journal-title":"Int J Rad Appl Instrum B"},{"key":"1415_CR28","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/0883-2897(91)90013-B","volume":"18","author":"K Ishiwata","year":"1991","unstructured":"Ishiwata K, Ido T, Kawamura M, Kubota K, Ichihashi M, Mishima Y. 4-Borono-2-[18F]fluoro-D,L-phenylalanine as a target compound for boron neutron capture therapy: tumor imaging potential with positron emission tomography. Int J Rad Appl Instrum B. 1991;18:745\u201351.","journal-title":"Int J Rad Appl Instrum B"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-019-01415-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12149-019-01415-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-019-01415-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T23:44:20Z","timestamp":1603410260000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12149-019-01415-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,24]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["1415"],"URL":"https:\/\/doi.org\/10.1007\/s12149-019-01415-z","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,24]]},"assertion":[{"value":"29 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}